Original research article| Volume 99, ISSUE 4, P239-243, April 2019

Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies



      This study describes hormonal contraception services provided by pharmacists and characterizes patient populations utilizing the service at one supermarket-based pharmacy chain in California and Oregon.

      Study design

      This is a descriptive study of 391 pharmacies in California and Oregon within a supermarket-based pharmacy chain providing hormonal contraception services and the patients who utilized those services in a 6.5-month period between August 2016 and February 2017. Data were extracted from pharmacy prescription records and available visit documentation forms to describe services provided and patient characteristics.


      During the study period, 381 trained pharmacists from the pharmacy chain provided hormonal contraception services in 391 pharmacy locations in Oregon and California. A total of 2117 visits were completed and 1970 hormonal contraception prescriptions were issued and dispensed during the study period. Researchers were able to access documentation for 676 visits (32%). Patients from various age groups (range 13–55 years old) and geographical locations (22 states total) utilized the service. Most had health insurance (74%), had seen a primary care provider in the past year (89%) and were previous hormonal contraception users (91%). Contraceptive methods prescribed include pill (n=1886, 95.7%), patch (n=31, 1.6%), vaginal ring (n=51, 2.6%) and injectable (n=2, 0.1%).


      Following scope of practice expansion, pharmacists in a community-based pharmacy setting are serving as an access point for women to obtain hormonal contraception services and supplies.


      This study provides an initial look at California's and Oregon's expansion of hormonal contraception prescribing authority to pharmacists. The service was available across all pharmacy locations of a supermarket-based chain in California and select locations in Oregon and utilized by diverse populations of patients. Pharmacists effectively provided hormonal contraception services and supplies to most patients seeking hormonal contraception.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Finer L.B.
        • Zolna M.R.
        Shifts in intended and unintended pregnancies in the United States, 2008–2011.
        N Engl J Med. 2016; 374: 843-852
        • Committee on Health Care for Underserved Women
        Access to contraception. Committee opinion no. 615.
        Obstet Gynecol. 2015; 125: 250-255
        • Grindlay K.
        • Grossman D.
        Prescription birth control access among U.S. women at risk of unintended pregnancy.
        J Women's Health (Larchmt). 2016; 25: 249-254
      1. Insurance coverage of contraceptives.
        Guttmacher Institute
        Date accessed: August 4, 2018
        • Gardner J.S.
        • Miller L.
        • Downing D.F.
        • Le S.
        • Blough D.
        • Shotorbani S.
        Pharmacist prescribing of hormonal contraceptives: results of the direct access study.
        J Am Pharm Assoc. 2008; 48: 212-221
      2. California Business and Profession Code 4052.3.
        (Available at:)
      3. Oregon Board of Pharmacy. 689.689 and 855-019-0400 through 855-019-0435.
        (Available at:)
      4. CA Board of Pharmacy proposed regulation: §1746.1 protocol for pharmacists furnishing self-administered hormonal contraception.
      5. Standard procedures algorithm for Oregon RPh prescribing of contraceptives.
        • USMEC
        • Charlton B.M.
        • Molgaard-Nielsen D.
        • Svanstrom H.
        • Wohlfahrt J.
        • Pasternak B.
        • Melbye M.
        Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study.
        BMJ. 2016; 352
        • Xu H.
        • Eisenberg D.L.
        • Madden T.
        • Secura G.M.
        • Peipert J.F.
        Medical contraindications in women seeking combined hormonal Contraception.
        Obstet Gynecol. 2014; 210
        • Potter J.E.
        • White K.
        • Hopkins K.
        • Amastae J.
        • Grossman D.
        Contraception: Choices women make along the US–Mexico border.
        Am J Public Health. 2010; 100: 1130-1136
        • Batra P.
        • Rafie S.
        • Zhang Z.
        • Singh A.V.
        • Bird C.E.
        • Sridhar A.
        • et al.
        An evaluation of the implementation of pharmacist-prescribed hormonal contraceptives in California.
        Obstet Gynecol. 2018; 131: 850-855
      6. Assembly Bill No. 1114. Chapter 602.
      7. Senate Bill No. 999. Chapter 499.
        • Steenland M.W.
        • Rodriguez M.I.
        • Marchbanks P.A.
        • Curtis K.M.
        How does the number of oral contraceptive pill packs dispensed or prescribed affect continuation and other measures of consistent and correct use? A systematic review.
        Contraception. 2013; 87: 603-610
      8. Poster presentation ACOG 2018 annual meeting on 4/27/2018 (California State Law (SB-999) and implementation: dispensing a year-long supply of prescription birth control [2E] Gelareh Nikpour, MD UCLA Department of Obstetrics and Gynecology, Los Angeles, CA Antoinette Allen, BA, Sally Rafie, PharmD, BCPS, Radhika Rible, MD, and Angela Chen, MD, MPH).